Trajenta Duo 2.5/1000 Tablet — Uses, Dosage & Benefits

Linagliptin 2.5 mg + Metformin hydrochloride 1000 mg (prolonged/extended-release may vary by pack; confirm pack label)

Linagliptin is a DPP-4 inhibitor that increases incretin levels, leading to glucose-dependent insulin release and reduced glucagon secretion. Metformin decreases hepatic glucose production, reduces intestinal glucose absorption and improves insulin sensitivity, lowering blood glucose without causing significant hypoglycaemia when used alone.

Oral tablet. Take exactly as prescribed, usually twice daily with meals (or as directed) to reduce stomach upset. Swallow whole with water; do not crush/chew if the pack is extended-release; follow label instructions. Monitor blood glucose regularly.

Always follow your doctor's prescription. Do not self-medicate.